20 µg recombinant hepatitis B vaccine at months 0, 1, and 6
2018ZX10721202001002001
Approved mab active
Quick answer
20 µg recombinant hepatitis B vaccine at months 0, 1, and 6 for Hepatitis B Vaccine is a Approved program (mab) at China SXT Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hepatitis B Vaccine
- Phase
- Approved
- Modality
- mab
- Status
- active